Analysis of the Clinical Efficacy of Glimepiride Combined with Insulin in the Treatment of Elderly Diabetes
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

Diabetes
Glimepiride
Insulin
Hypoglycemia

DOI

10.26689/jcnr.v8i9.8339

Submitted : 2024-08-27
Accepted : 2024-09-11
Published : 2024-09-26

Abstract

Objective: To explore the clinical efficacy and incidence of hypoglycemia in the treatment of elderly diabetes with glimepiride combined with insulin. Methods: A total of 100 patients diagnosed with diabetes in Qinghai Red Cross Hospital from January 2018 to January 2019 were selected and divided into an observation group and a control group according to the order of their visits, with 50 patients in each group. The observation group was treated with glimepiride combined with insulin, while the control group was treated with insulin alone. The blood sugar indicators, including glycated hemoglobin (HbA1c), fasting blood glucose (FBG), and 2-hour postprandial blood glucose (2h PBG), were compared between the two groups. Additionally, the incidence of hypoglycemia was compared, and the causes of hypoglycemia were analyzed and summarized, proposing corresponding countermeasures. Results: The glycated hemoglobin value of the observation group was lower than that of the control group, and the statistical analysis showed a significant difference (t = 3.54, P < 0.05). The fasting blood glucose value in the observation group was lower than that in the control group, with statistically significant differences (t = 4.08, P < 0.05). The 2-hour postprandial blood glucose value in the observation group was also lower than that in the control group, with a significant difference (t = 3.82, P < 0.05). The incidence of hypoglycemia in the observation group was 10%, while it was 56% in the control group, with a statistically significant difference between the two groups (χ2 = 5.813, P < 0.05). Conclusion: The efficacy of glimepiride combined with insulin in the treatment of elderly diabetes is significantly higher than that of insulin alone, with a lower incidence of hypoglycemia.

References

[1] Sun B, He F, Gao Y, et al., 2019, Prognostic Impact of Visit-to-Visit Glycemic Variability on the Risks of Major Adverse Cardiovascular Outcomes and Hypoglycemia in Patients with Different Glycemic Control and Type 2 Diabetes. Endocrine, 64(3): 536–543. https://doi.org/10.1007/s12020-019-01893-1
[2] Tuhackova M, Urbanova J, Brunerova L, et al., 2019, Etanol a Riziko Hypoglykemie u Pacientu s Diabetes Mellitus 1. Typu: Strucny Prehled Pro Klinickou Praxi [Ethanol and Risk of Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Brief Overview for Clinical Practice]. Vnitr Lek, 65(4): 303.
[3] Broz J, Urbanova J, 2019, Ramcovy Pohled na Epidemiologii Hypoglykemie u Diabetes Mellitus 1. a 2. Typu [A General View of Epidemiology of Hypoglycemia in Type 1 and Type 2 Diabetes Mellitus]. Vnitr Lek, 65(4): 289–294.
[4] Rossi MC, Nicolucci A, Ozzello A, et al., 2019, Impact of Severe and Symptomatic Hypoglycemia on Quality of Life and Fear of Hypoglycemia in Type 1 and Type 2 Diabetes. Results of the Hypos-1 Observational Study. Nutr Metab Cardiovasc Dis, 29(7): 736–743. https://doi.org/10.1016/j.numecd.2019.04.009
[5] Shah BR, Walji S, Kiss A, et al., 2019, Derivation and Validation of a Risk-Prediction Tool for Hypoglycemia in Hospitalized Adults With Diabetes: The Hypoglycemia During Hospitalization (HyDHo) Score. Can J Diabetes, 43(4): 278–282.e1. https://doi.org/10.1016/j.jcjd.2018.08.061
[6] Wolnik B, Orlowska-Kunikowska E, Blaszkowska M, et al., 2019, The Phenomenon of HbA1c Stability and the Risk of Hypoglycemia in Long-Standing Type 1 Diabetes. Diabetes Res Clin Pract, 152: 96–102. https://doi.org/10.1016/j.diabres.2019.05.010
[7] Meng F, Chang G, 2018, Analysis of the Causes of Hypoglycemia During the Treatment of Diabetic Patients. Electronic Journal of Clinical Medical Literature, 5(82): 39 + 42.
[8] Cao Y, 2018, Analysis of Hypoglycemia in Elderly Patients with Type 2 Diabetes. Practical Journal of Diabetes, 14(6): 47–48.
[9] Fan J, Yao C, 2018, Clinical Diagnosis and Treatment Analysis of 60 Cases of Elderly Diabetics with Hypoglycemia. World Latest Medicine Information Digest, 18(A1): 118.
[10] Wang Y, 2019, Clinical Analysis of 28 Cases of Elderly Diabetics with Hypoglycemia. China Modern Drug Application, 13(2): 72–73.
[11] Huang Y, Zhou Y, 2019, Exploration of the Causes of Hypoglycemia During Diabetes Treatment. Research on Women’s Health in China and Abroad, 2019(1): 48 + 146.
[12] Tie M, 2018, Analysis of the Causes of Hypoglycemia in Diabetic Patients During Treatment. Electronic Journal of Clinical Medical Literature, 5(99): 25 + 28.
[13] Zhou Y, Zhang Y, Wang S, et al., 2018, Investigation of Risk Factors for Nocturnal Hypoglycemia in Type 2 Diabetic Patients with Intensive Insulin Therapy. Internal Medicine Theory and Practice, 13(6): 375–378.
[14] Du B, 2019, Health Management of Type 2 Diabetic Patients with Recurrent Hypoglycemia. New World of Diabetes, 22(1): 137–138.
[15] Ou Y, 2019, Observation of Emergency Treatment Methods and Outcomes for Diabetic Patients with Hypoglycemic Coma. World Latest Medicine Information Digest, 19(13): 88.
[16] Liu J, 2019, Clinical Analysis and Preventive Measures for Hypoglycemia in Elderly Diabetic Patients. World Latest Medicine Information Digest, 19(9): 71 + 73.
[17] Liang Y, Zhang H, 2019, Blood Glucose Fluctuations and Hypoglycemia Risks of Different Treatment Regimens for Type 2 Diabetes. Practical Journal of Diabetes, 15(1): 17–18.
[18] Xiao L, Chi J, Meng L, et al., 2019, Study on the Relationship Between Different Correction Methods of Hypoglycemia in Diabetic Patients and Blood Glucose Elevation. Nursing Research, 33(5): 843–846.